Why Your Annual GP Check-Up Misses 80% of What Matters

A standard GP check-up in Switzerland typically covers the basics: blood pressure, weight, a lipid panel, perhaps blood glucose. In total, somewhere between 12 and 20 markers — out of the hundreds that circulate in your bloodstream telling a story about your health.

This is not a criticism of GPs. The system is designed for reactive care — treating what has already gone wrong. It was never designed to intercept what is quietly going wrong.

The 80% problem

Consider what a standard check-up does not typically measure:

• ApoB and ApoA1 — the markers that actually predict cardiovascular events, not just your total cholesterol
• Lipoprotein(a) — a genetically determined risk factor for heart attack that affects 1 in 5 people
• Fasting insulin and HOMA-IR — the only way to detect insulin resistance years before type 2 diabetes develops
• Free T3 and Free T4 — most GPs check TSH alone, missing subclinical thyroid dysfunction in millions of patients
• Cortisol and DHEA-S — the adrenal markers that explain why you feel exhausted even when your thyroid is "fine"
• hsCRP and IL-6 — systemic inflammation, the shared root of cardiovascular disease, dementia, and metabolic syndrome

This isn't a fringe idea. Prediabetes is defined precisely because rising blood sugar and insulin resistance can be detected years before a type 2 diabetes diagnosis — often long enough to reverse course through diet, exercise, and monitoring alone. Subclinical atherosclerosis works the same way: plaque can build quietly inside artery walls for years with no symptoms and a "normal" standard cholesterol panel. The biological signals exist well before the clinical event. Most standard check-ups simply aren't designed to look for them.

Why Swiss insurance doesn't cover the tests that matter

Switzerland's compulsory health insurance (KVG) is designed around cost-effectiveness at a population level. Preventative blood tests beyond a narrow standard set are generally not reimbursed for healthy, asymptomatic individuals. The logic is actuarial, not clinical.

This means that if you want to know whether your insulin sensitivity is declining, whether your testosterone is falling, or whether you have an elevated Lp(a) that triples your cardiac risk — you will need to arrange it yourself.

What the evidence says about early detection

The 2026 joint clinical guideline on managing cholesterol and lipids — issued by the American College of Cardiology, the American Heart Association, and nine other medical societies — makes this point directly: normal LDL and HDL cholesterol are not, in the guideline authors' own words, a "get out of jail free card." It explicitly recommends checking lipoprotein(a), apolipoprotein B, and hsCRP — none of which appear on a standard lipid panel — to refine a person's true cardiovascular risk, and recommends coronary artery calcium scoring when that risk remains unclear. A single Lp(a) reading of 125 nmol/L or higher is associated with roughly a 1.4-fold increase in lifetime risk of heart attack or stroke; above 250 nmol/L, that risk is at least double. Because Lp(a) is largely genetic and stable for life, it only needs to be measured once — yet fewer than 2% of adults have ever had it checked.

Early detection works because biology is not binary. Disease does not switch from "absent" to "present" overnight. It progresses along a continuum — and that continuum is measurable.

What a comprehensive panel actually looks like

At Aeonix, our Longevity Plus panel covers 135+ validated biomarkers across cardiovascular, metabolic, hormonal, nutritional, inflammatory, oncological, and musculoskeletal domains. Our Elite panel extends this to 150+. Every result is reviewed by a qualified physician and returned within 48 hours.

The difference is not incremental. It is the difference between a snapshot and a film — between knowing your total cholesterol and knowing whether your arterial walls are actually at risk.

"Most people spend more time choosing a car than understanding the machine they will live in for the rest of their lives."

A comprehensive screening does not tell you what is wrong. More importantly, it tells you what is right — and what quiet changes are underway before they become clinical events. That knowledge is the beginning of everything.